| 1. |
邱海波, 劉大為. 《2004嚴重感染和感染性休克治療指南》系列講座(1)2004嚴重感染和感染性休克治療指南概要[J].中國危重病急救醫學, 2004, 16(7):390-393.
|
| 2. |
程山鳳, 嚴長蘇, 鄭秀珍. ICU患者感染性休克死亡危險因素分析[J].中華醫院感染學雜志, 2015, 25(3):595-596, 602.
|
| 3. |
榮愛紅, 戴國興, 吳先正, 等. 感染性休克使用呼吸機的老年患者脫機失敗的相關因素[J].中國老年學雜志, 2014, 35(6):1589-1590.
|
| 4. |
陳陽, 侯英宇, 楊偉華, 等. 尿道熱6例報告[J].哈爾濱醫藥, 2005, 25(3):57-58.
|
| 5. |
Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy[J].Eur Urol, 2007, 51(4):899-906.
|
| 6. |
Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy[J].Urol Int, 2011, 86(4):448-452.
|
| 7. |
Abdulahad WH, Meijer JM, Kroese F, et al. B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjogren's syndrome a double-blind, placebo-controlled study[J].Arthritis Rheum, 2011, 63(4):1116-1123.
|
| 8. |
Charton M, Vallancien G, Veillon B, et al. Urinary tract infection in percutaneous surgery for renal calculi[J].J Urol, 1986, 135(1):15-17.
|
| 9. |
Mariappan P, Smith G, Moussa SA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis:a prospective controlled study[J].BJU Int, 2006, 98(5):1075-1079.
|
| 10. |
鄭凱, 張紹增, 王養民, 等. 尿道吸收熱7例報告[J].臨床泌尿外科雜志, 2003, 18(11):701-702.
|